These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 3090582)

  • 1. Evaluation of L-tryptophan for treatment of insomnia: a review.
    Schneider-Helmert D; Spinweber CL
    Psychopharmacology (Berl); 1986; 89(1):1-7. PubMed ID: 3090582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. L-tryptophan: a rational hypnotic with clinical potential.
    Hartmann E
    Am J Psychiatry; 1977 Apr; 134(4):366-70. PubMed ID: 320887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. L-tryptophan administered to chronic sleep-onset insomniacs: late-appearing reduction of sleep latency.
    Spinweber CL
    Psychopharmacology (Berl); 1986; 90(2):151-5. PubMed ID: 3097693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of sleep disorders with L-tryptophan. Uses of interval therapy in severe insomnia and hypnotic dependence].
    Schneider-Helmert D
    Fortschr Med; 1987 Feb; 105(6):113-6. PubMed ID: 3570119
    [No Abstract]   [Full Text] [Related]  

  • 5. Interval therapy with L-tryptophan in severe chronic insomniacs. A predictive laboratory study.
    Schneider-Helmert D
    Int Pharmacopsychiatry; 1981; 16(3):162-73. PubMed ID: 7033160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selectivity in response to L-tryptophan among insomniac subjects: a preliminary report.
    Lindsley JG; Hartmann EL; Mitchell W
    Sleep; 1983; 6(3):247-56. PubMed ID: 6353523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. L-tryptophan as a hypnotic in special patients.
    Fitten LJ; Profita J; Bidder TG
    J Am Geriatr Soc; 1985 Apr; 33(4):294-7. PubMed ID: 3989192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonorganic insomnia in generalized anxiety disorder. 2. Comparative studies on sleep, awakening, daytime vigilance and anxiety under lorazepam plus diphenhydramine (Somnium) versus lorazepam alone, utilizing clinical, polysomnographic and EEG mapping methods.
    Saletu B; Saletu-Zyhlarz G; Anderer P; Brandstätter N; Frey R; Gruber G; Klösch G; Mandl M; Grünberger J; Linzmayer L
    Neuropsychobiology; 1997; 36(3):130-52. PubMed ID: 9313245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sleep induced by L-tryptophan. Effect of dosages within the normal dietary intake.
    Hartmann E; Spinweber CL
    J Nerv Ment Dis; 1979 Aug; 167(8):497-9. PubMed ID: 469515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zaleplon: a review of its use in the treatment of insomnia.
    Dooley M; Plosker GL
    Drugs; 2000 Aug; 60(2):413-45. PubMed ID: 10983740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. L-tryptophan + oxprenolol: a new approach to the treatment of insomnia.
    Gnirss F; Schneider-Helmert D; Schenker J
    Pharmakopsychiatr Neuropsychopharmakol; 1978 Jul; 11(4):180-5. PubMed ID: 353833
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of L-tryptophan on sleep onset insomniacs.
    Brown CC; Horrom NJ; Wagman AM
    Waking Sleeping; 1979 Apr; 3(2):101-8. PubMed ID: 227180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and side effects of chloral hydrate and tryptophan as sleeping aids in psychogeriatric patients.
    Linnoila M; Viukari M; Numminen A; Auvinen J
    Int Pharmacopsychiatry; 1980; 15(2):124-8. PubMed ID: 7002832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic insomnia: effects of tryptophan, flurazepam, secobarbital, and placebo.
    Hartmann E; Lindsley JG; Spinweber C
    Psychopharmacology (Berl); 1983; 80(2):138-42. PubMed ID: 6410442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypnotic discontinuation in chronic insomnia: impact of psychological distress, readiness to change, and self-efficacy.
    Belleville G; Morin CM
    Health Psychol; 2008 Mar; 27(2):239-48. PubMed ID: 18377143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The insomnia of 'sleeping in a strange place': effects of l-tryptophane.
    Hartmann E; Elion R
    Psychopharmacology (Berl); 1977 Jul; 53(2):131-3. PubMed ID: 408839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Main neuroendocrine features and therapy in primary sleep troubles.
    Amihăesei IC; Mungiu OC
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(3):862-6. PubMed ID: 23272543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypnotic Discontinuation in Chronic Insomnia.
    Hintze JP; Edinger JD
    Sleep Med Clin; 2018 Jun; 13(2):263-270. PubMed ID: 29759276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subjective versus objective evaluation of hypnotic efficacy: experience with zolpidem.
    Kryger MH; Steljes D; Pouliot Z; Neufeld H; Odynski T
    Sleep; 1991 Oct; 14(5):399-407. PubMed ID: 1759092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long term efficacy and withdrawal of zopiclone: a sleep laboratory study.
    Pecknold J; Wilson R; le Morvan P
    Int Clin Psychopharmacol; 1990 Apr; 5 Suppl 2():57-67. PubMed ID: 2117623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.